Not All Prostate Cancer is the Same

Pinterest LinkedIn Tumblr +

In today’s special episode of The Oncology Podcast, our Host Rachael Babin chats to Professor Damien Bolton and Chris McNamara about why not all prostate cancers are the same.

The discussion is focused on the way men with advanced prostate cancer feel and the emotions they experience as well as important information gaps that may impact on their ability to make shared decisions about their clinical management. Rachael, Damien and Chris explore the perceptions of patients living with different stages of prostate cancer across the Asia-Pacific (APAC) region including Australia, Japan and China and review the PCFA’s Prostate Cancer Survivorship Essentials Framework.

Professor Damien Bolton, is a researcher and urologist who has performed over 1000 robot assisted radical prostatectomies. Christopher McNamara is Head of Community Services at the Prostate Cancer Foundation of Australia.


Papers and Helpful Links:

Akakura K, Bolton D, Grillo V, Mermod N. Not all prostate cancer is the same – patient perceptions: an Asia-Pacific region study. BJU Int. 2020 Sep;126 Suppl 1:38-45. doi: 10.1111/bju.15129. Epub 2020 Aug 2. PMID: 32521568. Access online here.

Dunn J, Green A, Ralph N, Newton R, Kneebone A, Frydenberg M, Chambers SK. Prostate Cancer Survivorship Essentials Framework: Guidelines for Practitioners (2020). British Journal of Urology International. Access online here.

PCFA Website: Survivorship Essentials Framework Infographic

PCFA Website: Publications for Recently Diagnosed Men and Their Families


Today’s Podcast Guests:

Professor Damien Bolton

Damien Bolton is a Professor in the University of Melbourne Department of Surgery at the Austin Hospital and Urologist at the Olivia Newton John Cancer Centre with an interest in endoscopic management of urinary tract pathology.

After training in Melbourne and at the University of California San Francisco he has over 90 published papers and book chapters, and has acted as Chair of the Cancer Council Victoria committee on Urogenital Cancer.

Currently he is a member of international consultative committees on urinary stone disease and on urogenital cancer. Damien has particular interests in urinary stone disease and laparoscopic treatment of urinary tract cancers.

Find Damien on Twitter here: @damien_bolton

Mr Christopher McNamara

Christopher McNamara is Head of Community Service at the Prostate Cancer Foundation of Australia.

Chris is a respected leader within his field and works tirelessly campaigning for men’s health issues. With a wide-ranging background in primary healthcare and men’s health promotion, Chris has particular expertise in community services and is passionate about building capacity to improve outcomes for men affected by prostate cancer. Over the past few years Chris has been a PCFA Prostate Cancer Specialist Nurse and has helped to significantly boost awareness of prostate cancer. Chris is a current active member and board member elect for the Australian Men’s Health Forum.

In addition to his educational efforts at the local level, Chris has also served as a speaker and panellist at national and international urological meetings for professional bodies including the Urological Association of Asia, the Urological Society of Australia and New Zealand, the Asia Pacific Prostate Cancer Conference, and the Queensland Urological Nursing Society. Chris is passionate about connecting rural and remote communities to prostate cancer information and access to services they require.

Find Chris on Twitter here: @ProsCa_Nurse

Rachael Babin

Rachael Babin is Editor-in-Chief of The Oncology Newsletter, Publisher of Oncology News Host of The Oncology Podcast and Producer of The Oncology Journal Club. For regular oncology updates for healthcare professionals, please subscribe to The Oncology Newsletter.

Connect with us on Twitter @OncologyNewsAus

 

 


Thank you:

With thanks to Damien Bolton, Chris McNamara, Nicki Sambuco and Graham Knowles.

This episode is proudly sponsored by Janssen, the Pharmaceutical Companies of Johnson & Johnson.  Learn more at www.janssen.com/australia.

Approval code: CP-231222

Share.

About Author

The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.

Leave A Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.